Luca Sorvillo
Overview
Explore the profile of Luca Sorvillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sapio L, Sorvillo L, Illiano M, Chiosi E, Spina A, Naviglio S
Molecules
. 2015 Sep;
20(9):15910-28.
PMID: 26340617
Due to its expression profile, triple-negative breast cancer (TNBC) is refractory to the most effective targeted therapies available for breast cancer treatment. Thus, cytotoxic chemotherapy represents the mainstay of treatment...
2.
Spina A, Di Maiolo F, Esposito A, Sapio L, Chiosi E, Sorvillo L, et al.
Biores Open Access
. 2013 Mar;
1(6):324-32.
PMID: 23515360
Breast cancer is one of the most common malignancies and a major cause of cancer death among women worldwide. The high mortality rate associated with breast cancer is mainly due...
3.
Spina A, Sapio L, Esposito A, Di Maiolo F, Sorvillo L, Naviglio S
Biores Open Access
. 2013 Mar;
2(1):47-54.
PMID: 23515235
Inorganic phosphate (Pi) is an essential nutrient for living organisms. It plays a key role in diverse physiological functions, including osteoblast differentiation and skeletal mineralization. Relevantly, Pi is emerging as...
4.
Spina A, Sorvillo L, Chiosi E, Esposito A, Di Maiolo F, Sapio L, et al.
Oncol Rep
. 2013 Mar;
29(5):1689-96.
PMID: 23446517
Novel therapeutic approaches are required for the treatment of osteosarcoma. Combination chemotherapy is receiving increased attention in order to identify compounds that may increase the therapeutic index of clinical anticancer...
5.
Spina A, Sorvillo L, Esposito A, Borgia A, Sapio L, Naviglio S
Curr Pharm Des
. 2013 Feb;
19(30):5394-403.
PMID: 23394088
Inorganic phosphate (Pi) is an essential nutrient to living organisms. It plays a key role in diverse biological processes, including osteoblast differentiation and skeletal mineralization. Maintenance of proper Pi homeostasis...
6.
Spina A, Di Maiolo F, Esposito A, DAuria R, Di Gesto D, Chiosi E, et al.
Front Biosci (Landmark Ed)
. 2013 Jan;
18(1):133-44.
PMID: 23276914
Breast cancer is a major cause of cancer death in women in the world. Triple-negative breast cancers, which accounts for 10-20% of all mammary tumours, are characterised by an aggressive...
7.
Spina A, Sorvillo L, Di Maiolo F, Esposito A, DAuria R, Di Gesto D, et al.
J Cell Physiol
. 2012 Jun;
228(1):198-206.
PMID: 22674530
Osteosarcoma is the most common malignant primary bone tumor in children and adolescents. The clinical outcome for osteosarcoma remains discouraging despite aggressive surgery and intensive radiotherapy and chemotherapy regimens. Thus,...
8.
Naviglio S, Di Gesto D, Romano M, Sorrentino A, Illiano F, Sorvillo L, et al.
Cancer Biol Ther
. 2009 Aug;
8(12):1183-90.
PMID: 19662684
Elevation of cAMP inhibits the proliferation and expression of transformed phenotype in several cell types, including breast cancer cells. Leptin has been shown to act as a mitogen/survival factor in...
9.
Naviglio S, Caraglia M, Abbruzzese A, Chiosi E, Di Gesto D, Marra M, et al.
Expert Opin Ther Targets
. 2008 Dec;
13(1):83-92.
PMID: 19063708
Background: cAMP is a second messenger that plays a role in intracellular signal transduction of various stimuli. a major function of cAMP in eukaryotes is activation of cAMP-dependent protein kinase...
10.
Chiosi E, Spina A, Sorrentino A, Romano M, Sorvillo L, Senatore G, et al.
J Interferon Cytokine Res
. 2007 Jul;
27(7):589-97.
PMID: 17651020
Doxorubicin (Doxo) is a widely used anticancer drug given for the treatment of leukemias, lymphomas, and solid tumors. Despite its potent antitumor effects, the cardiotoxicity of this drug limits its...